Patients regain weight after stopping Eli Lilly's Zepbound, study says
Publishing timestamp: 2023-12-11 16:48:22
Summary
Patients who took Eli Lilly's weight loss drug Zepbound regained around half of the weight they lost after stopping the treatment, according to new data. The study suggests that continued therapy is necessary to maintain significant weight loss. Some analysts believe Zepbound could become the best-selling drug of all time.
Sentiment: MIXED
Keywords: business news, breaking news, pharmaceuticals, health care industry, business, eli lilly and co, biotech and pharmaceuticals, science, biotechnology, novo nordisk a/s,